Gene Query: MRPL33

Dataset Description Geneva Score
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 25.69
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 25.39
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 23.34
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 23.34
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 22.57
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 20.08
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 18.72
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 18.19
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 17.28
Single-cell analysis of human kidney organoids 17.11
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 16.74
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 16.06
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 15.66
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 15.59
Identification of transcription start sites for human A549 cell line using ReCappable-seq 15.46
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 15.35
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 14.83
RNA-sequencing of healthy human skeletal myocytes 14.41
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 14.29
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 14.29
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 13.49
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 13.34
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 13.08
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 12.58
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 12.13
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 12.04
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 12.04
SLAM-seq for K562 endogenous mRNA decay 12.01
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 11.96
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.84
An integrative analysis of non-coding regulatory DNA variations associated with autism 11.72
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 11.59
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 11.38
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 10.93
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 10.88
RNA sequencing of matched nephrectomy samples [RNA-seq] 10.83
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 10.83
Generating Patterned Kidney Organoids for Studying Development and Diseases 10.67
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 10.65
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 10.53
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 10.48
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 10.48
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 10.48
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 10.18
Global analysis of enhancer targets: Mosaic-seq 10.16
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 10.05
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 9.99
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 9.92
Comprehensive comparative analysis of 5’ end RNA sequencing methods 9.92
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 9.83
Systematic discovery of endogenous human ribonucleoprotein complexes 9.82
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 9.33
Peptidomimetic blockade of MYB in acute myeloid leukemia 9.33
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 9.23
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 9.18
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 9.09
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 9.09
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 9.03
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 8.96
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 8.96
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 8.66
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 8.62
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 8.53
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 8.53
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 8.44
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 8.44
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 8.43
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 8.39
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 8.35
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 8.35
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 8.31
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 8.29
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 8.24
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 8.16
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 8.14
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 8.07
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 7.89
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 7.89
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 7.81
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 7.8
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.8
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 7.72
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 7.69
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 7.65
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 7.64
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 7.61
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 7.46
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 7.4
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 7.35
CROP-Seq in Primary Human T Cells 7.26
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 7.24
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 7.19
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 7.18
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 7.13
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 7.06
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 7.05
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 6.99
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 6.97
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 6.96
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 6.92
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 6.84
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 6.84
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 6.84
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 6.84
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 6.81
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.75
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 6.66
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 6.66
TT-Seq captures the human transient transcriptome 6.63
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 6.58
Impact of dieldrin on transcription in Jurkat T cells 6.57
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 6.53
Genome wide expression change by RNF168 knocking down in NEC cells 6.52
MOF acetyl transferase regulates transcription and respiration in mitochondria 6.45
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 6.41
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.41
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 6.38
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 6.36
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 6.3
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 6.29
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 6.25
Real-time observation of light-controlled transcription in living cells 6.22
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 6.2
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 6.16
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 6.16
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 6.08
Human Treg IL-12 stimulation 5.94
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 5.93
SUV420H2 knockdown in PANC-1 5.92
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 5.9
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 5.89
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 5.84
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.84
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.84
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 5.83
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 5.81
Transcriptomic analyssis following EHMT1/2 inhibition 5.79
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 5.78
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 5.78
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 5.76
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 5.73
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 5.7
snRNAs as regulators of alternative splicing 5.66
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 5.62
Transcriptome of human white and brown adipose tissue biopsies 5.6
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 5.6
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 5.57
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 5.5
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 5.5
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 5.5
TCF7L1 knockdown in pancreatic cancer 5.48
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 5.48
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 5.48
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 5.45
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 5.44
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 5.4
Nucleoporin-mediated regulation of cell identity genes 5.39
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 5.38
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 5.35
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 5.31
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 5.31
METTL3 promotes translation in human cancer cells 5.26
Identification of renal resident macrophages across species 5.21
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 5.17
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 5.11
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 5.08
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 5.08
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 5.05
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 5.05
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.04
Transcriptomic analysis of the HOTAIR-regulated genes 5.02
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.98
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 4.97
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 4.97
Gene expression signatures of innate lymphoid cells from human blood 4.94
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.91
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 4.91
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 4.89
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.89
Transcriptome analysis of kidney organoids 4.87
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.87
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 4.87
ARID1A and ARID1B loss in HCT116 and TOV21G cells 4.87
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 4.85
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 4.85
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 4.84
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 4.81
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 4.81
Global transcriptome analysis of HAP1 cells 4.8
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 4.8
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.78
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 4.76
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.74
HNF1A deficiency impairs β-cell fate, granule maturation and function 4.74
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 4.73
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 4.71
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 4.71
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 4.7
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 4.7
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 4.7
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 4.68
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 4.64
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 4.6
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 4.6
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 4.57
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 4.51
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.5
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.48
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.48
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.42
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 4.38
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 4.37
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.36
RNA-seq of MDA-MB-231 cells with TET1 knockout 4.34
The effect of Abl kinases on non-small cell carcinoma global transcriptome 4.34
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.33
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.26
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.25
Trans-differentiation of human adult peripheral blood T cells into neurons 4.2
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 4.18
The comparison of high-throughput single-cell RNA-seq methods 4.16
Transcriptome-wide response to synthetic chromatin protein PcTF 4.16
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 4.13
RNA-seq of YB5 cells treated with Proscillaridin A 4.12
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 4.1
High-throughput sequencing of PROMPT-enriched samples. 4.1
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 4.1
Transcription control by the ENL YEATS domain in acute leukemia 4.09
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 4.09
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 4.06
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.03
MRTF activates TEAD-YAP target gene expression 3.98
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 3.98
Cajal bodies are linked to genome conformation [RNA-Seq] 3.98
Cajal bodies are linked to genome conformation 3.98
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.96
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.96
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 3.95
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 3.95
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 3.93
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 3.89
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 3.87
Transcriptomic analysis of LSD1 3.87
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.81
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 3.79
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 3.76
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 3.76
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 3.73
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 3.73
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 3.72
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 3.71
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.7
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.7
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 3.68
miRNAs affected by antagomiR-17 treatment 3.67
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 3.65
Small-molecule targeting of brachyury transcription factor addiction in chordoma 3.61
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 3.61
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 3.61
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 3.6
Transcriptional profiling of microglia; current state of the art and future perspectives 3.56
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 3.56
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 3.52
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 3.52
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.51
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 3.49
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 3.49
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.48
Transcriptome analysis of SKI knock-out in HL60 cells 3.48
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.46
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 3.43
Exploring ILF2 regulatory genes by next-generation sequencing 3.43
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 3.4
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 3.39
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.39
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.26
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 3.25
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.24
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 3.23
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.22
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.22
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 3.21
Mapping interactions for the TNIP2 hub protein 3.21
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.17
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 3.13
Differentiation enhances Zika virus infection in neuronal brain cells 3.1
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 3.07
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.06
Human Treg IFNg/IL-10 subpopulations 3.04
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 3.0
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 2.99
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 2.99
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.98
O-glcnAc reprograms cellular energetics 2.93
Active translatome profiling with RiboLace in MCF7 cells 2.93
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 2.9
RNA editing in nascent RNA affects pre-mRNA splicing 2.85
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.84
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.84
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  2.83
RNA-seq of cells with TET1 knockout 2.82
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 2.78
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 2.76
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.7
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.68
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.66
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.66
SOX11 knockdown in B-ALL cell lines 2.63
Solid phase chemistry to covalently and reversibly capture thiolated RNA 2.6
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 2.58
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 2.58
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.57
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 2.57
Modeling Human Cancer-induced Cachexia (Human) 2.53
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.52
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.48
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 2.44
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 2.44
Effect of PBK knockdown on C4-2 cell transcriptome 2.43
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.42
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.42
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 2.42
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 2.36
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.36
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.35
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.35
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.35
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.35
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.34
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 2.34
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.31
IRF1 regulates IFN dependent and independent gene expression 2.31
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.31
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 2.29
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 2.28
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.27
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.26
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.26
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.25
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.25
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.23
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 2.22
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 2.22
Effect of ILF3 on translation during homeostasis and the antiviral response 2.16
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.08
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 2.08
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 2.06
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 2.03
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.03
Dilated cardiomyopathy vs Myocarditis 2.0
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.99
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.99
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 1.98
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.96
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 1.95
Measure transcript integrity using RNA-seq data 1.95
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.95
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 1.94
Genome-wide analysis of the Integrator complex 1.91
Genome-wide analysis of the Integrator complex (HTS) 1.91
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.9
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.9
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.88
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.88
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.85
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.85
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 1.85
Androgen Receptor-regulated genes in prostate cancer cells 1.85
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 1.83
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 1.83
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 1.8
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.79
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.79
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.78
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.75
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.74
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.72
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.71
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.68
Iron response of HepG2 cells 1.65
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.64
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 1.64
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.62
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.61
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 1.59
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.59
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 1.58
Function and hormonal regulation of GATA3 in human first trimester placentation 1.58
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.55
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.55
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.52
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 1.51
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 1.51
SF3B1 Degron knockdown RNA-seq 1.46
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.44
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.44
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.44
Chromatin landscape of human visceral and subcutaneous adipocytes 1.43
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 1.4
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 1.39
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 1.39
Targeting MTHFD2 in Acute Myeloid Leukemia 1.38
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.38
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.37
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.35
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.35
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 1.3
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.29
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.25
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.19
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.18
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 1.17
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 1.17
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.16
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.14
The cohesin complex prevents Myc-induced replication stress 1.13
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.01
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.98
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.98
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.97
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.97
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.96
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 0.93
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.92
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 0.91
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 0.91
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.9
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.9
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.9
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.87
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.86
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.85
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.85
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.79
Dermal endothelial cells of type 2 diabetic patients 0.77
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.76
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 0.71
Specific molecular signatures underlie response to decitabine in CMML 0.69
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.69
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.66
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.65
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.65
p53 activity results in DNA replication fork processivity 0.65
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.62
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.62
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.6
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.59
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.59
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.57
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 0.57
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 0.56
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 0.56
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.55
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.52
Universal alternative splicing of noncoding exons 0.5
Regulation of hypoxia-inducible factor activity by ZMYND8 0.48
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 0.45
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.43
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.42
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.41
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.4
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 0.34
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.34
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.33
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.33
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.32
Single-cell analysis of adult human ovary using 10X genomics 0.32
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.3
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 0.3
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 0.3
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.26
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.24
Morphological and molecular characterization of human dermal lymphatic collectors 0.22
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.17
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.17
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 0.17
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 0.17
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.13
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.13
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 0.13
Role of cervicovaginal microbiota in genital inflammation 0.12
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.11
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 0.09
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 0.09
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.08
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.07
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.07
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.07
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.06
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 0.06
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.06
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.06
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.05
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.05
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.04
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.04
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.04
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.03
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.01
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation